One-year survival in patients with acute myocardial infarction and a saphenous vein graft culprit treated with primary angioplasty

American Journal of Cardiology

Volumn 91, Issue 10, 2003, Pages 1250-1254

  Nguyen, Thanh T ^b   O'Neill, William W ^b   Grines, Cindy L ^b   Stone, Gregg W ^b   Brodie, Bruce R ^b   Cox, David A ^b   Grines, Lorelei L ^b   Boura, Judith A ^b   Dixon, Simon R ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEPARIN; IONIC CONTRAST MEDIUM; IOXAGLIC ACID;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY WALL; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING TIME; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART REINFARCTION; HIGH RISK PATIENT; HUMAN; INFUSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; RISK FACTOR; SAPHENOUS VEIN GRAFT; STATISTICAL ANALYSIS; STROKE; SURGICAL MORTALITY; SURVIVAL TIME; THROMBECTOMY; TREATMENT OUTCOME; VEIN OCCLUSION;

EID: 0038064113     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00277-7     Document Type: Article

References (16)

1. Indications for fibrinolytic therapy in suspected acute myocardial infarction collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients . Lancet. 343:1994;311-322.
2. Lee K.L., Woodlief L.H., Topol E.J., Weaver W.D., Betriu A., Col J., Simoons M., Aylward P., van de Werf F., Califf R.M. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. Circulation. 91:1995;1659-1668.
3. Peterson L.R., Chandra N.C., French W.J., Rodgers W.J., Weaver W.D., Tiefenbrunn A.J. Reperfusion therapy in patients with acute myocardial infarction and prior coronary artery bypass graft surgery (National Registry of Myocardial Infarction-2). Am J Cardiol. 84:1999;1287-1291.
4. Stone G.W., Grines C.L., Browne K.F., Marco J., Rothbaum D., O'Keefe J., Hartzler G.O., Overlie P., Donohue B., Chelliah N., et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era the Primary Angioplasty in Myocardial Infarction (PAMI) trial . J Am Coll Cardiol. 25:1995;370-377.
5. Stone G.W., Brodie B.R., Griffin J.J., Grines L., Boura J., O'Neill W.W., Grines C.L. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. J Am Coll Cardiol. 35:2000;605-611.
6. Labinaz M., Sketch M.H., Ellis S.G., Abramowitz B.M., Stebbins A.L., Pieper K.S., Holmes D.R., Califf R.M., Topol E.J. Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy. Am Heart J. 141:2001;469-477.
7. Suwaidi J.A., Velianou J.L., Berger P.B., Mathew V., Garratt K.N., Reeder G.S., Grill D.E., Holmes D.R. Primary percutaneous coronary interventions in patients with acute myocardial infarction and prior coronary artery bypass grafting. Am Heart J. 142:2001;452-459.
8. Stone G.W., Marsalese D., Brodie B.R., Griffin J.J., Donohue B., Costantini C., Balestrini C., Wharton T., Esente P., Spain M., et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol. 29:1997;1459-1467.
9. Stone G.W., Brodie B.R., Griffin J.J., Morice M.C., Costantini C., St Goar F.G., Overlie P.A., Popma J.J., McDonnell J., Jones D., O'Neill W.W., Grines C.L. Prospective multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction in-hospital and 30-day results of the PAMI stent pilot trial . J Am Coll Cardiol. 31:1998;23-30.
10. Grines C.L., Cox D.A., Stone G.W., Garcia E., Mattos L.A., Giamburtolomei A., Brodie B.R., Madonna O., Eijgelshoven M., Lansky A.J., O'Neill W.W., Norice M.C. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med. 341:1999;1949-1956.
11. Esente P., Kaplan A.V., Ford J.K., Martin J.L., Ayres M., Kosinski E.J., Lasorda D.M., Graham M., Gallant P., Grines L.L., Grines C.L. Local intramural heparin delivery during primary angioplasty for acute myocardial infarction results of the local PAMI pilot study . Cathet Cardiovasc Intervent. 47:1999;237-242.
12. Grines C.L., Booth D.C., Nissen S.E., Gurley J.C., Bennett K.A., O'Connor W.N., DeMaria A.N. Mechanism of acute myocardial infarction in patients with prior coronary artery bypass grafting and therapeutic implications. Am J Cardiol. 65:1990;1292-1296.
13. Kahn J.K., Rutherford B.D., McConahay D.R., Johnson W., Giorgi L.V., Ligon R., Hartzler G.O. Usefulness of angioplasty during acute myocardial infarction in patients with prior coronary artery bypass grafting. Am J Cardiol. 65:1990;698-702.
14. Watson P.S., Hadjipetrou P., Cox S.V., Pyne C.T., Gossman D.E., Piemonte T.C., Eisenhauer A.C. Angiographic and clinical outcomes following acute infarct angioplasty on saphenous vein grafts. Am J Cardiol. 83:1999;1018-1021.
15. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 329:1993;1615-1622.
16. Silva J.A., White C.J., Collins T.J., Ramee S.R. Morphologic comparison of atherosclerotic lesions in native coronary arteries and saphenous vein grafts with intracoronary angioscopy in patients with unstable angina. Am Heart J. 136:1998;156-163.